22.120.18% ( +0.04 )
Delay Midday Break: Nov 16, 11:30:00Financials
Q3 2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: Panlong Pharmaceutical(002864) the Revenue is 195.39 M (-26.94%);the EBIT is 24.4 M (-33.25%);the EPS is 0.101 (-54.11%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.20B26.94%
----
----
EBIT
0.02B33.25%
----
----
EPS
0.10154.11%
----
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateApr 23, 2027
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly
